Stockreport

Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers [Yahoo! Finance]

Vaxart, Inc.  (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
PDF “Initiating this study is an important step toward Vaxart's goal of developing a vaccine that may reduce the significant global health threat norovirus poses to childre [Read more]